XML 104 R117.htm IDEA: XBRL DOCUMENT v3.19.3
UNAUDITED QUARTERLY DATA - Effect of Restatement on Previously Filed Statement of Cash Flows (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 36 Months Ended
Dec. 31, 2017
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Dec. 31, 2017
Dec. 31, 2016
Mar. 31, 2018
Mar. 31, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2019
OPERATING ACTIVITIES:                                          
Net loss   $ (10,541) $ (4,510) $ (10,657) $ (6,320) $ (1,696) $ (3,223) $ (4,194) $ (2,171) $ (2,938) $ (925) $ (232) $ (3,370) $ (6,365) $ (3,602) $ (9,588) $ (4,527) $ (32,028) $ (11,284) $ (7,465) $ (50,800)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:                                          
Non-cash stock-based compensation                 409       211 984 445 1,424 678 1,750 1,794 1,214  
(Gain) loss on disposal of property and equipment                 (18)         (80) (34) (99) (59) 672 (131) (177)  
Non-cash interest and amortization of debt discount                 17       139 94 65 118 98 301 140 113  
Bad debt expense                 168       199 382 331 510 460 2,534 471 557  
Provision for inventory reserve                 221       248 1,091 480 1,361 804 3,172 1,467 877  
Depreciation and amortization                 1,370       1,603 3,278 3,164 5,586 4,679 8,009 7,829 5,956  
Excess tax benefits                 67         67   67   0 67 0  
Change in fair value of warrant liabilities                     0 0 1,490   1,490   1,490 0 0 1,490  
Deferred income taxes, net                 16       15 (159) 30 (154) 46 (7) (183) 62  
Recognition of deferred gain from sale-leaseback transactions                 0       0 0 0 0 0     0  
Changes in operating assets and liabilities:                                          
Accounts receivable                 (3,149)       (1,003) (5,332) (2,418) (9,964) (2,316) (8,488) (6,234) (2,538)  
Finance receivables, net                 9,168       (5) 7,332 2,119 8,202 (2,180) (8) 2,228 (10,832)  
Sale of finance receivables                               2,051   0 2,280 0  
Inventory, net                 (3,900)       (2,713) (7,615) (3,403) (7,777) (2,957) (5,242) (3,661) (4,463)  
Prepaid expenses and other current assets                 (103)       (124) (2) (442) 355 (454) (395) 377 153  
Accounts payable and accrued expenses                 (1,490)       (2,543) 7,704 (2,700) 15,255 1,262 873 16,933 8,874  
Deferred revenue                 171       (59) 570 326 351 157 (98) 351 115  
Income taxes payable                 (55)       (3) (40) 3 (30) 4 254 (13) (8)  
Net cash (used in) provided by operating activities                 721       (5,915) 1,909 (4,146) 7,668 (2,815) (28,701) 12,431 (6,072)  
INVESTING ACTIVITIES:                                          
Purchase of property and equipment, including rentals                 (720)       (623) (1,734) (1,752) (3,138) (2,536) (4,346) (3,978) (3,787)  
Proceeds from sale of property and equipment                 45         157 61 252 105 116 298 348  
Cash paid for acquisitions, net of cash acquired                           (65,181)   (65,181)   0 (65,181) 0  
Net cash used in investing activities                 (675)       (623) (66,758) (1,691) (68,067) (2,431) (4,230) (68,861) (3,439)  
FINANCING ACTIVITIES:                                          
Proceeds from collateralized borrowing from the transfer of finance receivables $ 1,100                         1,075   1,075   0 1,075 0  
Cash used in retirement of common stock                         (31)   (31) (156) (31) (81) (552) (31)  
Proceeds from exercise of common stock warrants                         6,193   6,193   6,193 0 0 6,193  
Payment of debt issuance costs                           445   445 90 156 445 90  
Proceeds from exercise of common stock options                               109   42 141 0  
Proceeds from issuance of long-term debt                           25,100   25,100   0 25,100 0  
Proceeds from revolving credit facility                           10,000   12,500   0 12,500 0  
Repayment of revolving credit facility                               (2,500)   0 (2,500) 0  
Issuance of common stock in public offering, net                 39,888         39,888   39,888   0 104,796 0  
Repayment of line of credit                           (7,111) (106) (7,111) (106) 0 (7,111) (106)  
Repayment of capital lease obligations and long-term debt                 (809)       (698) (1,043) (1,457) (3,751) (2,212) (23,254) (5,355) (2,982)  
Net cash (used in) provided by financing activities                 39,079       5,464 67,464 4,599 64,709 3,754 (23,569) 127,649 2,984  
Net (decrease) increase in cash and cash equivalents                 39,125       (1,074) 2,615 (1,238) 4,310 (1,492) (56,500) 71,219 (6,527)  
Cash and cash equivalents at beginning of year         $ 83,964 17,055 15,360 51,870 12,745 17,780 18,034 18,198 19,272 12,745 19,272 12,745 19,272 83,964 12,745 19,272 19,272
Cash and cash equivalents at end of year 15,360 $ 27,464       83,964 17,055 15,360 51,870 12,745 17,780 18,034 18,198 15,360 18,034 17,055 17,780 $ 27,464 83,964 12,745 27,464
As Previously Reported                                          
OPERATING ACTIVITIES:                                          
Net loss             1,160 (12,516) (213) 243 136 233 (2,464) (12,729) (2,231) (11,569) (2,095)     (1,852)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:                                          
Non-cash stock-based compensation                 576       211 1,356 445 2,005 678     1,214  
(Gain) loss on disposal of property and equipment                 (18)         (83) (31) (112) (59)     (177)  
Non-cash interest and amortization of debt discount                 15       105 86 26 100 98     113  
Bad debt expense                 118       97 291 450 506 577     764  
Provision for inventory reserve                 0       0 0 0 0 0     0  
Depreciation and amortization                 1,492       1,301 3,476 2,564 5,858 3,774     5,591  
Excess tax benefits                 67         67   67          
Change in fair value of warrant liabilities                     0 0 1,490   1,490   1,490     1,490  
Deferred income taxes, net                 (535)       (115) 8,537 (115) 6,400 94     54  
Recognition of deferred gain from sale-leaseback transactions                 (43)       (215) (93) (430) (143) (646)     (560)  
Changes in operating assets and liabilities:                                          
Accounts receivable                 (3,192)       (1,038) (5,290) (2,347) (12,972) (2,388)     (2,988)  
Finance receivables, net                 8,771       (5) 7,958 2,119 11,114 (2,113)     (12,119)  
Sale of finance receivables                               0          
Inventory, net                 (3,648)       (2,223) (5,822) (2,689) (5,624) (2,042)     (2,399)  
Prepaid expenses and other current assets                 (217)       (224) (606) (542) (564) (406)     (304)  
Accounts payable and accrued expenses                 (2,168)       (3,175) 6,950 (3,840) 13,808 (1,239)        
Deferred revenue                 0       0 0 0 (185) 0     0  
Income taxes payable                 0       (10) 40 (12) 0 (18)     (8)  
Net cash (used in) provided by operating activities                 1,005       (6,265) 4,138 (5,143) 8,689 (4,295)     (6,771)  
INVESTING ACTIVITIES:                                          
Purchase of property and equipment, including rentals                 (992)       (810) (1,767) (1,944) (3,005) (2,818)     (4,041)  
Proceeds from sale of property and equipment                 45         157 61 252 105     348  
Cash paid for acquisitions, net of cash acquired                           (65,181)   (65,181)          
Net cash used in investing activities                 (947)       (810) (66,791) (1,883) (67,934) (2,713)     (3,693)  
FINANCING ACTIVITIES:                                          
Proceeds from collateralized borrowing from the transfer of finance receivables                           0   0          
Cash used in retirement of common stock                         (31)   (31) (156) (31)     (31)  
Proceeds from exercise of common stock warrants                         6,193   6,193   6,193     6,193  
Payment of debt issuance costs                           445   445 90     90  
Proceeds from exercise of common stock options                               109          
Proceeds from issuance of long-term debt                           25,100   25,100          
Proceeds from revolving credit facility                           10,000   12,500          
Repayment of revolving credit facility                               (2,500)          
Issuance of common stock in public offering, net                 39,888         39,888   39,888          
Repayment of line of credit                           (7,111) 0 (7,111) 0     (106)  
Repayment of capital lease obligations and long-term debt                 (821)       (161) (2,138) (374) (3,778) (556)     (2,029)  
Net cash (used in) provided by financing activities                 39,067       6,001 65,294 5,788 63,607 5,516     3,937  
Net (decrease) increase in cash and cash equivalents                 39,125       (1,074) 2,641 (1,238) 4,362 (1,492)     (6,527)  
Cash and cash equivalents at beginning of year           17,107 15,386 51,870 12,745 17,780 18,034 18,198 19,272 12,745 19,272 12,745 19,272   12,745 19,272 19,272
Cash and cash equivalents at end of year 15,386           17,107 15,386 51,870 12,745 17,780 18,034 18,198 15,386 18,034 17,107 17,780     12,745  
Adjustments                                          
OPERATING ACTIVITIES:                                          
Net loss             (4,383) 8,322 (1,958) (3,181) (1,061) (465) (906) 6,364 (1,371) 1,981 (2,432)     (5,613)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:                                          
Non-cash stock-based compensation                 (167)       0 (372) 0 (581) 0     0  
(Gain) loss on disposal of property and equipment                 0         3 (3) 13 0     0  
Non-cash interest and amortization of debt discount                 2       34 8 39 18 0     0  
Bad debt expense                 50       102 91 (119) 4 (117)     (207)  
Provision for inventory reserve                 221       248 1,091 480 1,361 804     877  
Depreciation and amortization                 (122)       302 (198) 600 (272) 905     365  
Excess tax benefits                 0         0   0          
Change in fair value of warrant liabilities                     0 0 0   0   0     0  
Deferred income taxes, net                 551       130 (8,696) 145 (6,554) (48)     8  
Recognition of deferred gain from sale-leaseback transactions                 43       215 93 430 143 646     560  
Changes in operating assets and liabilities:                                          
Accounts receivable                 43       35 (42) (71) 3,008 72     450  
Finance receivables, net                 397       0 (626) 0 (2,912) (67)     1,287  
Sale of finance receivables                               2,051          
Inventory, net                 (252)       (490) (1,793) (714) (2,153) (915)     (2,064)  
Prepaid expenses and other current assets                 114       100 604 100 919 (48)     457  
Accounts payable and accrued expenses                 678       632 754 1,140 1,447 2,501        
Deferred revenue                 171       (59) 570 326 536 157     115  
Income taxes payable                 (55)       7 (80) 15 (30) 22     0  
Net cash (used in) provided by operating activities                 (284)       350 (2,229) 997 (1,021) 1,480     699  
INVESTING ACTIVITIES:                                          
Purchase of property and equipment, including rentals                 272       187 33 192 (133) 282     254  
Proceeds from sale of property and equipment                 0         0 0 0 0     0  
Cash paid for acquisitions, net of cash acquired                           0   0          
Net cash used in investing activities                 272       187 33 192 (133) 282     254  
FINANCING ACTIVITIES:                                          
Proceeds from collateralized borrowing from the transfer of finance receivables                           1,075   1,075          
Cash used in retirement of common stock                         0   0 0 0     0  
Proceeds from exercise of common stock warrants                         0   0   0     0  
Payment of debt issuance costs                           0   0 0     0  
Proceeds from exercise of common stock options                               0          
Proceeds from issuance of long-term debt                           0   0          
Proceeds from revolving credit facility                           0   0          
Repayment of revolving credit facility                               0          
Issuance of common stock in public offering, net                 0         0   0          
Repayment of line of credit                           0 (106) 0 (106)     0  
Repayment of capital lease obligations and long-term debt                 12       (537) 1,095 (1,083) 27 (1,656)     (953)  
Net cash (used in) provided by financing activities                 12       (537) 2,170 (1,189) 1,102 (1,762)     (953)  
Net (decrease) increase in cash and cash equivalents                 0       0 (26) 0 (52) 0     0  
Cash and cash equivalents at beginning of year           $ (52) (26) 0 0 0 0 0 0 0 0 0 0   $ 0 0 $ 0
Cash and cash equivalents at end of year $ (26)           $ (52) $ (26) $ 0 $ 0 $ 0 $ 0 $ 0 $ (26) $ 0 $ (52) $ 0     $ 0